EPO and hypertensive disorder: Adverse events related to rHuEPO are rare and consist of hypertension, headache, reaction at injection site, increased numbers of platelets in the blood and an increased risk of thrombosis.44 Generally, after a doubling of the initial EPO dose, a further increment of the dose is not advisable because it increases the risk of thrombosis.